Longeveron Inc. (LGVN)
NASDAQ·Healthcare·Biotechnology
$2.62
-3.68%
Mkt Cap $20.02M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+281.7%
Consensus $10.00 vs current $2.62
NASDAQ·Healthcare·Biotechnology
$2.62
-3.68%
Mkt Cap $20.02M
Buy
1
Hold
1
Sell
0
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
+281.7%
Consensus $10.00 vs current $2.62